RESUMO
Fluorescein labeled Me-SATE T20 models were synthesized. The high uptake of these prooligos in HeLa cells was confirmed by fluorescence microscopy, flow cytometry and by spectrofluorometry.
Assuntos
Oligonucleotídeos/farmacocinética , Timidina/análogos & derivados , Fluoresceínas/análise , Fluoresceínas/química , Células HeLa , Humanos , Microscopia de Fluorescência , Oligonucleotídeos/análise , Nucleotídeos de Pirimidina/análise , Nucleotídeos de Pirimidina/farmacocinética , Timidina/análise , Timidina/farmacocinéticaRESUMO
The fate of a dodecathymidine prodrug in cell extract was monitored by MALDI-TOF MS. This technique allows a facile identification and a relative quantification of metabolites produced. We showed that the relative peak intensities were similar to the relative metabolite proportions that permitted the determination of their half-lives. The oligonucleotide prodrug was fully metabolized to yield the T12 phosphorothioate likely through a carboxyesterase mediated mechanism.
Assuntos
Oligonucleotídeos/farmacocinética , Pró-Fármacos/farmacocinética , Nucleotídeos de Pirimidina/farmacocinética , Timidina/análogos & derivados , Biotransformação , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por MatrizRESUMO
Phosphorothioate oligodeoxynucleotides containing the C-5 propyne analogs of uridine and cytidine bind RNA with high affinity and are potent antisense inhibitors of gene expression. In a cellular assay, gene-specific antisense inhibition occurred at nanomolar concentrations of oligonucleotide, was dose-dependent and exquisitely sensitive to sequence mismatches, and was correlated with the melting temperature and length of oligonucleotide. Activity was independent of RNA target site and cell type but was detectable only when the oligonucleotides were microinjected or delivered with cell-permeabilizing agents. These oligonucleotides may have important applications in therapy and in studies of gene function.
Assuntos
Oligonucleotídeos Antissenso/farmacologia , Nucleotídeos de Pirimidina/farmacologia , RNA/efeitos dos fármacos , Tionucleotídeos/farmacologia , Alcinos/farmacologia , Animais , Sequência de Bases , Linhagem Celular , Chlorocebus aethiops , Humanos , Dados de Sequência Molecular , Oligonucleotídeos Antissenso/farmacocinética , Nucleotídeos de Pirimidina/farmacocinética , Ratos , Tionucleotídeos/farmacocinéticaRESUMO
The effect of high-dose uridine on body temperatures of rabbits and man has been studied in relation to plasma concentrations of uridine and its catabolite uracil. Uridine induced fever in both rabbits and man. High-dose cytidine had no influence on body temperature in rabbits. Plasma concentrations of uridine were between 1 and 1.5 mM at 30 min after an iv bolus injection of 400 mg uridine/kg in rabbits and reached peak levels of 2 mM after a 1-hr infusion of 12 g uridine/m2 in man. The plasma concentration of cytidine in rabbits was about 0.5 mM and that of uridine was 0.30 mM at 30 min after an iv bolus injection of 400 mg cytidine/kg. The mean residence time for uridine in patients and rabbits varied between 80 and 195 min. The area under the plasma concentration-time curve (AUC) for uridine in rabbits was 2.0 mmol.hr/liter, and that for cytidine was 0.6 mmol.hr/liter. A large AUC for uridine indicates a prolonged exposure of tissues to uridine, which might lead to extensive formation of degradation products. The administration of some of these catabolites, dihydrouracil (at 20-40 mg/kg), carbamyl-beta-alanine (at 60 mg/kg), and beta-alanine (at 300-400 mg/kg), resulted in a significant increase in body temperature. It is concluded that the change in body temperature associated with uridine administration was not due to bacterial pyrogens but that one of the degradation products might be involved in thermoregulation.